Loading organizations...
Loading organizations...
Development of nucleic acid aptamers for diagnostics and therapeutics.
Aptamer Group has raised $6.8M across 2 funding rounds.
Aptamer Group has raised $6.8M in total across 2 funding rounds.
Aptamer Group has raised $6.8M in total across 2 funding rounds.
Aptamer Group's investors include Meneldor.
Aptamer Group has raised $6.8M across 2 funding rounds. Most recently, it raised $4.6M Other Equity in July 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 31, 2023 | $4.6M Other Equity | ||
| Jun 29, 2018 | $2.2M Series A | Meneldor |